Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Ofatumumab

Hazard - P - B - T - Risk Exempt

Information

The use of amino acids, proteins and peptides is not considered to have any environmental impact. Arzerra (ofatumumab) is now withdrawn from use in Sweden since 2019-02-28.

Author: Health and Medical Care Administration, Region Stockholm